[1]
|
Levin, E.G., Santell, L. and Osborn, K.G. (1997) The Expression of Endothelial Tissue Plasminogen Activator in Vivo: A Function Defined by Vessel Size and Anatomic Location. Journal of Cell Science, 110, 139-148.
|
[2]
|
World Health Organisation (2005) Preventing Chronic Diseases: A Vital Investment. Geneva.
|
[3]
|
Dalal, P., Bhattacharjee, M., Vairale, J. and Bhat, P. (2007) UN Millenium Development Goals: Can We Halt the Stroke Epidemic in India? Annals of Indian Academy of Neurology, 10, 130-136.
http://dx.doi.org/10.4103/0972-2327.34791
|
[4]
|
Gupta, R., Joshi, P., Mohan, V., Reddy, S. and Yusuf, S. (2008) Epidemology and Causation of Coronary Heart Disease and Stroke in India. Heart, 94, 16-26. http://dx.doi.org/10.1136/hrt.2007.132951
|
[5]
|
Feigin, V., Lawes, C., Bennet, D., Barker-Cello, S. and Parag, V. (2009) Worldwide Stroke Incidence and Early Case Fatality in 56 Population Based Studies: A Systemic Review. The Lancet Neurology, 8, 355-369.
http://dx.doi.org/10.1016/S1474-4422(09)70025-0
|
[6]
|
Shah, B. and Mathur, P. (2006) Workshop Report on Stroke Surveillance in India. Division of Noncommunicable Diseases, Indian Council of Medical Research, New Delhi.
|
[7]
|
Taylor, F.C. (2012) Stroke in India, South Asia Network for Chronic Disease Fact Sheets http://www.sancd.org/.
http://sancd.org/uploads/pdf/factsheet_Stroke.pdf
|
[8]
|
Hoylaerts, M., Rijken, D.C., Lijnen, H.R. and Collen, D. (1982) Kinetics of the Activation of Plasminogen by Human Plasminogen Activator. Role of Fibrin. The Journal of Biological Chemistry, 257, 2912-2919.
|
[9]
|
Ranby, M. (1982) Studies on Kinetics of Plasminogen Activation by Tissue Plasminogen Activator. Biochimica et Biophysica Acta (BBA), 704, 461-446. http://dx.doi.org/10.1016/0167-4838(82)90068-1
|
[10]
|
Kristensen, P., Larsson, L.-I., Nielsen, L.S., Grondahl-Hansen, J., Andreasen, P.A. and Dano, K. (1984) Human Endothelial Cells Contain One Type of Plasminogen Activator. FEBS Letters, 168, 33-37.
http://dx.doi.org/10.1016/0014-5793(84)80201-X
|
[11]
|
Saksela, O., Moscatelli, D., Sommer, A. and Rifkin, D.B. (1988) Endothelial Cell-Derived Heparan Sulfate Binds Basic Fibroblast Growth Factor and Protects It from Proteolytic Degradation. The Journal of Cell Biology, 107, 743-751.
http://dx.doi.org/10.1083/jcb.107.2.743
|
[12]
|
Levin, E.G. and Loskutoff, D.K. (1982) Cultured Bovine Endothelial Cells Produce Both Urokinase and Tissue-Type Plasminogen Activators. The Journal of Cell Biology, 94, 631-636. http://dx.doi.org/10.1083/jcb.94.3.631
|
[13]
|
Speiser, W., Anders, E., Preissner, K.T., Wagner, O. and Muller-Berghaus, G. (1987) Differences in Coagulant and Fibrinolytic Activities of Cultured Human Endothelial Cells Derived from Omental Tissue Microvessels and Umbilical Veins. Blood, 69, 964-967.
|
[14]
|
Wojta, J., Jones, R.L., Binder, B.R. and Hoover, R.L. (1988) Reduction in P02 Decreases the Fibrinolytic Potential of Cultured Bovine Endothelial Cells Derived from Pulmonary Arteries and Lung Microvasculature. Blood, 71, 1703-1706.
|
[15]
|
Van Zonneveld, A.J., Veerman, H. and Pannekoek, H. (1986) Autonomous Functions of Structural Domains on Human Tissue-Type Plasminogen Activator. Proceedings of the National Academy of Sciences of the United States of America, 83, 4670-4674. http://dx.doi.org/10.1073/pnas.83.13.4670
|
[16]
|
Van Zonneveld, A.J., Veerman, H. and Pannekoek, H. (1986) The Interaction of the Finger and the Kringle-2 Domain of Tissue-Type Plasminogen Activator with Fibrin: Inhibition of Kringle-2 Binding to Fibrin by Epsilon-Amino Caproic Acid. Journal of Biological Chemistry, 261, 14214-14218.
|
[17]
|
Dudek, G.A., Kloczewiak, M., Budzyński, A.Z., Latallo, Z.S. and Kopec, M. (1970) Characterisation and Comparison of Macromolecular End Products of Fibrinogen and Fibrin Proteolysis by Plasmin. Biochimica et Biophysica Acta (BBA), Protein Structure, 214, 44-51. http://dx.doi.org/10.1016/0005-2795(70)90068-1
|
[18]
|
Corcoran, M.L., Hewitt, R.E., Kleiner Jr., D.E. and Stetler-Stevenson, W.G. (1996) MMP-2: Expression, Activation and Inhibition. Enzyme Protein, 49, 7-19.
|
[19]
|
Keski-Oja, J., Lohi, J., Tuuttila, A., Tryggvason, K. and Vartio, T. (1992) Proteolytic Processing of the 72,000-Da Type IV Collagenase by Urokinase Plasminogen Activator. Experimental Cell Research, 202, 471-476.
http://dx.doi.org/10.1016/0014-4827(92)90101-D
|
[20]
|
Ohira, T., Shahar, E., Chambless, L.E., Rosamond W.D., Mosley Jr., T.H. and Folsom, A.R. (2006) Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study. Stroke, 37, 2493-2498.
http://dx.doi.org/10.1161/01.STR.0000239694.19359.88
|
[21]
|
Arrastia, R.D. (2000) Homocysteine and Neurologic Disease. Archives of Neurology, 57, 1422-1426.
|
[22]
|
Modi, M., Prabhakar, S., Majumdar, S., Khullar, M., Lal, V. and Das, C.P. (2005) Hyperhomocysteinemia as a Risk Factor for Ischemic Stroke: An Indian Scenario. Neurology India, 53, 297-301.
http://dx.doi.org/10.4103/0028-3886.16927
|
[23]
|
(2005) Activase (Alteplase) Product Information. Genentech, South San Fransisco.
|
[24]
|
Frendl, A. and Csiba, L. (2011) Pharmacological and Non-Pharmacological Recanalization Strategies in Acute Ischemic Stroke. Frontiers in Neurology, 2, 00032. http://dx.doi.org/10.3389/fneur.2011.00032
|
[25]
|
Brown, D.L., Barsan, W.G., Lisabeth, L.D., Galler, M.E. and Morgenstern, L.B. (2005) Survey of Emergency Physicians about Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke. Annals of Emergency Medicine, 46, 56-60. http://dx.doi.org/10.1016/j.annemergmed.2004.12.025
|
[26]
|
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue Plasminogen Activator for Acute Ischemic Stroke. The New England Journal of Medicine, 333, 1581-1587.
http://dx.doi.org/10.1056/NEJM199512143332401
|
[27]
|
Liang, B.A., Lew, R. and Zivin, J.A. (2008) Review of Tissue Plasminogen Activator, Ischemic Stroke, and Potential Legal Issues. Archives of Neurology, 65, 1429-1433.
|
[28]
|
Griffiths, J.B. and Electricwala, A. (1987) Production of Tissue Plasminogen Activators from Animal Cells. Advances in Biochemical Engineering/Biotechnology, 34, 147-166.
|
[29]
|
Sarmientos, P., Duchesne, M., Denèfle, P., Boiziau, J., Fromage, N., Delporte, N., Parker, F., Lelièvre, Y., Mayaux, J.F. and Cartwright, T. (1989) Synthesis and Purification of Active Human Tissue Plasminogen Activator from Escherichia coli. Nature Biotechnology, 7, 495-501. http://dx.doi.org/10.1038/nbt0589-495
|
[30]
|
Qui, J., Swartz, J.R. and Georgiou, G. (1998) Expression of Active Human Tissue-Type Plasminogen Activator in Escherichia coli. Applied and Environmental Microbiology, 64, 4891-4896.
|
[31]
|
Pennica, D., Holmes, W.E., Kohr, W.J., Harkins, R.N., Vehar, G.A., Ward, C.A., Bennett, W.F., Yelverton, E., Seeburg, P.H., Heyneker, H.L., Goeddel, D.V. and Collen, D. (1983) Cloning and Expression of Human Tissue-Type Plasminogen Activator cDNA in E. coli. Nature, 301, 214-221. http://dx.doi.org/10.1038/301214a0
|
[32]
|
de Vos, A.M., Ultsch, M.H., Kelley, R.F., Padmanabhan, K., Tulinsky, A., Westbrook, M.L. and Kossiakoff, A.A. (1992) Crystal Structure of the Kringle 2 Domain of Tissue Plasminogen Activator at 2.4-.ANG Resolution. Biochemistry, 31, 270-279. http://dx.doi.org/10.1021/bi00116a037
|
[33]
|
Furlong, A.M., Thomsen, D.R., Marotti, K.R., Post, L.E. and Sharma, S.K. (1988) Active Human Tissue Plasminogen Activator Secreted from Insect Cells Using a Baculovirus Vector. Biotechnology and Applied Biochemistry, 10, 454-464.
|
[34]
|
Ogrydziak, D.M. (1993) Yeast Extracellular Proteases. Critical Reviews in Biotechnology, 13, 1-55.
http://dx.doi.org/10.3109/07388559309069197
|
[35]
|
Lubiniecki, A., Arathoon, R., Polastri, G., Thomas, J., Wiebe, M., Garnick, R., Jones, A., van Reis, R. and Builder, S. (1990) Selected Strategies for Manufacture and Control of Recombinant Tissue Plasminogen Activator Prepared from Cell Culture. In: Spier, R.E., Griffiths, J.B., Stephenne, J. and Crooy, P.J., Eds., Advances in Animal Cell Biology and Technology for Bioprocesses, Butterworths, London, 442-451.
|
[36]
|
Soleimani, M., Mahboudi, F., Davoudi, N., Amanzadeh, A., Azizi, M., Adeli, A., Rastegar, H., Barkhordari, F. and Mohajer-Maghari, B. (2007) Expression of Human Tissue Plasminogen Activator in the Trypanosomatid Protozoan Leishmania tarentolae. Biotechnology and Applied Biochemistry, 48, 55-61. http://dx.doi.org/10.1042/BA20060217
|